Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.335 EUR | +6.35% | -1.33% | -14.10% |
04-04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
Chart calendar Celyad Oncology SA
Upcoming events on Celyad Oncology SA
Past events on Celyad Oncology SA
04/04/2024 06:00 | Q4 2023 Earnings Release |
26/02/2024 | CAR-TCR Europe summit |
14/11/2023 13:00 | Extraordinary Shareholders Meeting |
09/11/2023 06:00 | Q3 2023 Earnings Release |
10/10/2023 | BioJapan Conference |
11/09/2023 | International Conference on Lymphocyte Engineering |
05/09/2023 12:00 | Q2 2023 Earnings Call |
04/09/2023 06:00 | Q2 2023 Earnings Release |
19/06/2023 | Immuno-Oncology Summit |
04/06/2023 | BIO International Convention |
05/05/2023 06:00 | Q1 2023 Earnings Release |
04/05/2023 | Annual General Meeting |
24/03/2023 12:00 | Q4 2022 Earnings Call |
23/03/2023 21:01 | Q4 2022 Earnings Release |
03/02/2023 06:00 | FY 2022 Sales and Revenue Release |
10/11/2022 06:01 | Q3 2022 Earnings Release |
05/08/2022 13:00 | Interim 2022 Earnings Call |
04/08/2022 | Interim 2022 Earnings Release |
24/05/2022 12:00 | H.C. Wainwright Global Life Sciences Investment Conference |
05/05/2022 21:01 | Q1 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 |
---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 0,01 0,00 - | 0,01 0,84 -99.4% | 0,00 5,40 - |
EBITDA Million EUR | Released Forecast Spread | -27,1 -36,7 26.18% | -15,2 -24,8 38.98% | -24,9 -26,3 5.48% |
EBIT Million EUR | Released Forecast Spread | -28,9 -34,1 15.25% | -17,0 -23,7 28.43% | -26,4 -27,2 2.95% |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -28,6 -34,0 15.83% | -17,2 -32,9 47.73% | -26,5 -28,4 6.64% |
Net income Million EUR | Released Forecast Spread | -28,6 -34,0 15.85% | -17,2 -29,1 40.83% | -26,5 -28,4 6.6% |
EPS EUR | Released Forecast Spread | -2,29 -1,80 -27.57% | -1,23 -2,01 38.89% | -1,70 -1,28 -32.81% |
Announcement Date | 24/03/20 | 24/03/21 | 24/03/22 |
Quarterly results
Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 |
---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 0,01 0,00 - | 0,01 1,29 -99.61% | 0,00 0,00 - | 0,00 0,00 - | 0,00 7,20 - |
EBIT Million EUR | Released Forecast Spread | -12,9 -17,5 26.11% | -16,6 -16,8 0.98% | -0,43 -16,4 97.36% | -14,9 -15,5 4.26% | -11,5 -11,8 2.66% |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -12,7 -17,5 27.59% | -16,6 -16,7 0.56% | -0,61 -16,3 96.28% | -14,9 -15,5 4.41% | -11,6 -13,2 12.01% |
Net income Million EUR | Released Forecast Spread | -12,7 -17,5 27.63% | -16,6 -16,7 0.54% | -0,61 -16,3 96.28% | -14,9 -15,5 4.41% | -11,7 -13,2 11.94% |
Announcement Date | 24/03/20 | 06/08/20 | 24/03/21 | 04/08/21 | 24/03/22 |
Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Celyad Oncology SA
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CYAD Stock
- Calendar Celyad Oncology SA